MRD Detection Emerges as a Catalyst for Advances in Colon Cancer
OncLive,
Peter Gibbs, MBBS, MD, FRACP For patients with colon cancer, traditional clinical and pathologic risk factors may soon take a…
Peter Gibbs, MBBS, MD, FRACP For patients with colon cancer, traditional clinical and pathologic risk factors may soon take a…
Although a majority of pancreatic cancer cells are highly dependent on endogenous biosynthesis of cholesterol, new research…
SAN FRANCISCO – Interrogation of the pancreatic cancer genome and transcriptome identifies distinct molecular subtypes that…
NEW YORK (GenomeWeb) — GeneCentric said today that it has exclusively licensed a next-generation sequencing-based pancreatic…